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ABSTRACT Candida auris is an enigmatic yeast that provides substantial global risk
in health care facilities and intensive care units. A unique phenotype exhibited by
certain isolates of C. auris is their ability to form small clusters of cells known as ag-
gregates, which have been to a limited extent described in the context of patho-
genic traits. In this study, we screened several nonaggregative and aggregative C.
auris isolates for biofilm formation, where we observed a level of heterogeneity
among the different phenotypes. Next, we utilized an RNA sequencing approach to
investigate the transcriptional responses during biofilm formation of a nonaggrega-
tive and aggregative isolate of the initial pool. Observations from these analyses in-
dicate unique transcriptional profiles in the two isolates, with several genes identi-
fied relating to proteins involved in adhesion and invasion of the host in other
fungal species. From these findings, we investigated for the first time the fungal rec-
ognition and inflammatory responses of a three-dimensional skin epithelial model to
these isolates. In these models, a wound was induced to mimic a portal of entry for
C. auris. We show that both phenotypes elicited minimal response in the model mi-
nus induction of the wound, yet in the wounded tissue, both phenotypes induced a
greater response, with the aggregative isolate more proinflammatory. This capacity
of aggregative C. auris biofilms to generate such responses in the wounded skin
highlights how this opportunistic yeast is a high risk within the intensive care envi-
ronment where susceptible patients have multiple indwelling lines.
IMPORTANCE Candida auris has recently emerged as an important cause of concern
within health care environments due to its ability to persist and tolerate commonly
used antiseptics and disinfectants, particularly when attached to a surface (biofilms).
This yeast is able to colonize and subsequently infect patients, particularly those that
are critically ill or immunosuppressed, which may result in death. We have under-
taken analysis on two different phenotypic types of this yeast, using molecular and
immunological tools to determine whether either of these has a greater ability to
cause serious infections. We describe that both isolates exhibit largely different tran-
scriptional profiles during biofilm development. Finally, we show that the inability to
form small aggregates (or clusters) of cells has an adverse effect on the organism’s
immunostimulatory properties, suggesting that the nonaggregative phenotype may
exhibit a certain level of immune evasion.
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Candida auris is a nosocomial pathogen first identified in 2009 (1). To date, thismultidrug-resistant organism has been identified in more than 40 countries on six
different continents, providing a substantial global risk in health care facilities and
intensive care units (2–4). It is postulated that the emergence of C. auris may have
coincided with climate change based on its particular attributes, resulting in a ther-
motolerant organism with the ability to persist in the environment before transmission
to humans (5).
A unique pathogenic trait exhibited by some isolates of C. auris is their ability to
form aggregates (Agg) (6–8). Despite the well-documented prevalence of C. auris
worldwide, relatively little is known about the Agg phenotype of the organism. The
existence of four geographically and phylogenetically distinct clades of the organism
(2), and a fifth recently proposed clade (9), has restricted definitive profiling of the C.
auris pathogenic mechanism of these aggregates in regard to biofilm-forming capa-
bilities, drug resistance pathways, and interactions with the host. Of the publications
that exist, some have documented characteristic pathogenic traits for both phenotypes
in vitro and in vivo (6, 10, 11). Others have shown that the Agg phenotype is inducible
under certain conditions (7, 8), while histological analyses of murine models have
shown that aggregates can accumulate in organs following C. auris infection (7, 12, 13).
Therefore, further studies are required to investigate this characteristic Agg phenom-
enon in C. auris isolates to fully comprehend the pathogenic pathways of the organism
and to understand how such mechanisms may differ from their nonaggregative
(non-Agg) counterparts.
Limited evidence also exists for studies investigating the interactions of C. auris with
components of the host, although several in vivo models have been employed to
document the virulence of C. auris. Of these models, Galleria mellonella larva infection
models and murine models of invasive candidiasis have shown various survival rates
postinfection with C. auris (6, 8, 10, 12–15), reaffirming that genetic variability among
clades impacts the organism’s virulence. However, such studies have been limited in
investigating the host immune response to the organism. Recently, Johnson et al.
utilized a zebrafish (Danio rerio) model to monitor C. auris-host cell interactions in vivo
(16). This work highlighted that C. auris (strain B11203 Indian isolate phylogenetically
part of the South Asian or India/Pakistan clade (2), which appeared to exhibit a non-Agg
phenotype) was resistant to neutrophil-mediated killing, suggesting that the organism
has the ability to persist incognito in the host (16). In vitro studies have shown
interactions between C. auris and epithelial tissue, emphasizing that the organism can
persist on skin. In this study, Horton and colleagues demonstrated that C. auris (B11203
strain, as above) formed high-burden biofilms on porcine skin biopsy specimens in the
presence of an artificial sweat medium (17). However, to date, no studies have docu-
mented the host inflammatory response to the non-Agg and/or Agg phenotype.
In this study, we sought to investigate the level of heterogeneity among different
non-Agg and Agg isolates. We deemed this pertinent given that such traits of heter-
ogeneity among isolates have previously been described for other Candida species,
significantly impacting clinical outcomes and mortality rates (18). To further investigate
this Agg versus non-Agg phenotype, transcriptome analyses were performed on plank-
tonic cells and biofilms of two selected isolates from the initial pool. Upon completion
of these analyses, we discovered that several genes associated with cell membrane
and/or cell wall proteins (e.g., cellular components) were upregulated in the Agg
biofilm. Such unique transcriptional profiles in respect to the cellular components led
us to investigate the host response following stimulation with both C. auris phenotypes
in vitro. For this, a two- and three-dimensional skin wound model was employed to
investigate the epithelial response to the Agg and non-Agg isolates of C. auris. Both
skin wound models exhibited different profiles to each isolate, indicating unique fungal
recognition and/or host response to the Agg and non-Agg phenotype. Interestingly,
there was minimal response by the host to C. auris without induction of the wound,
suggesting that the organism relies on the loss of tissue integrity to become invasive.
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The Agg phenotype is a unique trait of C. auris, one that can influence the
organism’s pathogenic traits in vitro and in vivo (6, 10, 11). To corroborate these
previous observations, differences in early and late biofilm formation were assessed
between non-Agg and Agg isolates of C. auris. A total of 26 non-Agg and Agg C. auris
clinical isolates were screened during early (4-h) and mature (24-h) biofilm growth
stages (Fig. 1A and B). Both sets of non-Agg and Agg C. auris isolates formed biofilms
in a time-dependent manner as assessed by crystal violet staining. With the exception
of C. auris NCPF 8993 (non-Agg) and NCPF 8996 (Agg), all isolates formed biofilms with
greater biomass after 24-h culture than after 4 h of culture (Fig. 1C and D). Although the
Agg phenotype tended to form biofilms with greater biomass at both 4 h and 24 h, we
observed no statistical differences when collectively comparing all nonaggregating and
aggregating isolates of C. auris at either time point (see Fig. S1A and B in the
supplemental material). From these data, it was clear that some isolates formed biofilms
with greater biomass than others, suggestive of a certain level of heterogeneity
between isolates of Agg and non-Agg phenotype, in line with previous observations (6,
10, 19). Similar trends of biofilm heterogeneity were observed when monitoring biofilm
formation via impedance measurements in real time at both time points in non-Agg
and Agg phenotype (Fig. 1E to H and Fig. S1C and D). These data support corroboration
of these unique phenotypes among isolates.
To further study the pathogenic and biofilm-forming characteristics of Agg and
non-Agg C. auris, transcriptional profiling of 24-h planktonic versus biofilm phenotypes
was performed. For these studies, two clinical isolates from the initial pool tested were
selected for analysis (non-Agg NCPF 8973 and Agg NCPF 8978, indicated by the red
points in Fig. 1). First, we found that a total of 701 genes were upregulated in
planktonic and/or biofilm form of Agg compared to the non-Agg phenotype, of which
450 genes were upregulated in the biofilm state (Fig. 2A). Conversely, fewer genes (430)
were upregulated in non-Agg C. auris in the planktonic, biofilm, or both states com-
pared to Agg C. auris counterparts, with 194 genes upregulated in the biofilm form
(Fig. 2B). In order to understand the functional processes related to differentially
expressed genes, a cutoff of twofold upregulation was used for gene ontology (GO)
analysis (adjusted P value of0.05). Upregulated genes in non-Agg versus Agg C. auris
biofilms normalized to planktonic cell expression involved three functional classes:
biological processes (BP), cellular components (CC), and metabolic functions (MF)
(Fig. S2A and B). Interestingly, most genes upregulated in the Agg biofilm belonged to
the CC functional class; more than 40 genes related to membrane and cell wall
constituents were upregulated in the Agg form compared to the non-Agg phenotype
(Fig. 2C). Several genes associated with fungal cell wall proteins were upregulated in
the Agg biofilms, including TSA1, ECM33,MP65, and PHR1 (Fig. S2C). Moreover, included
in these 40 genes were members of the ALS family of adhesins such as ALS1. In contrast,
in the non-Agg biofilms, the greatest changes in expression were observed for genes
belonging to functional classes of BP and MF (Fig. S2C). Only a small number of genes
belonging to cellular components were upregulated in the non-Agg biofilm compared
to the Agg biofilm (Fig. 2D). Of these genes, 20 genes belonging to the peroxisome,
glycine cleavage complex, myelin sheath, and glyoxysome were upregulated in the
non-Agg isolate.
The observed differences in the transcriptional profiles of genes belonging to the CC
of C. auris could impact the ability of the host to recognize the two phenotypes. For
example, key cellular components such as ALS proteins of other Candida species, such
as Candida albicans play important roles in aiding host colonization and orchestrating
the innate immune response (20, 21). However, it is currently unknown whether similar
mechanisms exist for C. auris. Therefore, the following section investigates whether a
non-Agg or Agg phenotype dictates the response by the host to C. auris. For this, a two-
and three-dimensional skin epithelial model was employed to study the host response
to the two C. auris isolates used above. For both coculture skin systems, a wound was
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FIG 1 Nonaggregative and aggregative Candida auris biofilm heterogeneity. Biomass and impedance measurements were used as measures of
biofilm formation of 26 isolates of C. auris (n 14 for the nonaggregative phenotype and n 12 for the aggregative phenotype). For biomass
(Continued on next page)
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induced to mimic the possible entry site of patients for C. auris in health care
environments. In the two-dimensional model containing adult human epidermal ker-
atinocytes (HEKa) cells, both isolates were significantly more cytotoxic to host cells
following induction of the wound (P  0.001) (Fig. 3A). Intriguingly, Agg C. auris was
significantly more cytotoxic than the non-Agg form in the wound model (P  0.01)
(Fig. 3A) It is noteworthy that wounded monolayers minus inoculum were comparable
to untreated monolayers (data not shown), suggesting that induction of the wound did
not induce cytotoxic effects on the cells. A similar trend in cytotoxicity was observed
between the two isolates in the three-dimensional model (Episkin, SkinEthic recon-
structed human epidermis [RHE]), although this did not reach statistical significance
(Fig. 3B). Interestingly, cytotoxicity of Agg and non-Agg C. auris were comparable in
both coculture models minus wounds.
To further study the host response in the three-dimensional system, a transcriptional
response in the tissue was investigated using a RT2 profiler array containing primers
specific for genes associated with inflammatory responses and/or fungal recognition
(Fig. 3C). Upon investigation, it was evident that the greatest changes in gene expres-
sion were observed in the wound models for both C. auris isolates. Importantly,
induction of the wound minus C. auris did not significantly alter the expression of any
of the genes arrayed. In the wound model, proinflammatory cytokine genes TNF and
IL1 (P  0.05) were significantly upregulated in RHE tissue cultured with non-Agg C.
auris (Fig. 3C). Conversely, the Agg phenotype of C. auris induced the greatest changes
in RHE; the expression of 8 of the 11 genes profiled (IL1, P  0.05; TNF, IL-6, CAMP,
P 0.01; CFS2, CFS3, CLEC7A, P 0.001; TLR4, P 0.0001) (Fig. 3C) were all significantly
upregulated following coculture compared to the untreated tissue.
In the three-dimensional coculture system, it was evident from histological and
fungus-specific periodic acid-Schiff (PAS) staining that both isolates of C. auris had
adhered to the peripheral keratinized layer of the RHE tissue (Fig. S3). Uninfected tissue
displayed a well-organized multilayered structure characteristic of skin epidermis in vivo
(22) (Fig. S3A). However, in infected tissue, there was no sign of C. auris infiltration into
the tissue (Fig. S3A and B) as seen with previous publications of skin tissue infection
models with invasive C. albicans (23, 24). Unfortunately, loss of tissue integrity in the
wounded model rendered them unsuitable for histological staining; therefore, at this
juncture, we were unable to visualize whether C. auris invaded the tissue at the wound
site. Nonetheless, given that the expression of several important cell membrane and
cell wall proteins are differentially regulated in non-Agg and Agg phenotypes of C. auris
biofilms, we wanted to assess the gene response of C. auris in the infected tissue. For
this, two key virulence factor genes belonging to the ALS and SAP families were
selected for analyses. Both these gene families are involved in translation of two key
proteins associated with Candida invasion of the host and associated virulence (25–27).
The two genes selected, ALS5 and SAP5, were both upregulated in the Agg phenotype
compared to the non-Agg C. auris isolate in the three-dimensional tissue model (Fig. 3D
and E). Such a response in the Agg isolate may begin to elucidate the mechanism by
which this phenotype generated a greater inflammatory response within the tissue.
DISCUSSION
Results of this study further indicate that the Agg phenotype of C. auris determines
its pathogenicity in vitro. This phenotype, first reported by Borman et al., is character-
FIG 1 Legend (Continued)
assessment, 1 106 fungal cells were seeded in 96-well plates, and biofilm developed for 4 h or 24 h prior to crystal violet staining. Panels A and
B show the differences in absorbance at 570 nm of the nonaggregative and aggregative phenotypes, respectively, at 4 h and 24 h. (C and D) The
heatmaps show the average absorbance at 570 nm for each individual isolate at both time points. The formation of C. auris biofilms in real time
was monitored using electron impedance measurements on the xCELLigence real-time cell analyzer. (E and F) Electron impedance measurements
are presented as cell index for all isolates and for biofilms developed for 4 h and 24 h, respectively. (G and H) The heatmaps depict the mean
cell index values for all nonaggregative (G) and aggregative (H) isolates. Red data points indicate the two isolates selected for further analyses
in this study (NCPF 8973 and NCPF 8978). Paired Student’s t tests were used for statistical analyses, and statistically significant differences for data
were determined and are indicated by bars and asterisks as follows: **, P  0.01; ***, P  0.001; ****, P  0.0001.
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FIG 2 Transcriptional profile of nonaggregative and aggregative Candida auris during biofilm formation. RNA from
planktonic cells and biofilms formed for 24 h of two isolates (NCPF 8973 and NCPF 8978) was used for RNA sequencing
(Continued on next page)
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ized in certain isolates by the formation of individual yeast cells mixed with large
aggregations in planktonic form (6). This aggregating behavior was later shown to
affect biofilm formation, antifungal susceptibility, and virulence of the organism (6, 10,
11, 19). Moreover, aggregation has recently been found to be an inducible trait
triggered by subinhibitory concentrations of triazole and echinocandin antifungals,
suggesting that treatment regimens must be carefully considered to combat C. auris
FIG 2 Legend (Continued)
and transcriptome analyses as described in the text. (A and B) Venn diagrams depict upregulated genes in aggregative (A)
or nonaggregative (B) phenotype in either the planktonic form (blue circle) or the biofilm form (red circle) or in both forms
(blue and red circle). (C and D) Gene distribution of significantly upregulated genes in biofilm forms were grouped for gene
ontology analysis. Genes upregulated that belong to the functional pathway cellular components (CC) are shown, while
the other two pathways (biological processes [BP] and metabolic functions [MF], respectively) are included in Fig. S2 in the
supplemental material. A cutoff twofold upregulation was used for gene ontology analysis using an adjusted P value
of0.05.
FIG 3 Cytotoxic and inflammatory effects of aggregative and nonaggregative Candida auris on skin
epithelial models in vitro. For these analyses, a two- and three-dimensional skin epithelial model was
used as schematically shown in Fig. 4. (A and B) First, cytotoxicity in the models was determined by
quantifying the amount of lactate dehydrogenase (LDH) released by the human adult epidermal
keratinocytes (HEKa) (A) and skin epidermis (B) following coculture with the aggregative (NCPF 8978) and
nonaggregative (NCPF 8973) isolates of C. auris. For this, data were presented as fold change relative to
the value for the PBS control. (C) To study the host response to C. auris, an RT2 profiler array containing
genes associated with inflammation and fungal recognition was utilized to assess the transcriptional
profile of the skin epidermis following stimulation. Data in the heatmap are presented as log2 fold
change relative to the value for the PBS control. (D and E) Finally, expression of two virulence genes, ALS5
and SAP5, was determined in the isolates. Values are presented as percent expression relative to the
fungus-specific housekeeping gene, -actin. All epithelial cells or tissues were infected in triplicate, and
statistical significance was determined from raw data threshold cycle (CT) values using unpaired Student’s
t tests for comparison of two variables or one-way ANOVA with Tukey’s multiple-comparison posttest for
more than two variables (*, P  0.05; ** and §§, P  0.01; ***, P  0.001; ****, P  0.0001).
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dependent on its Agg phenotype (8). In this study, we report a previously described
RNA-sequencing approach (28) in order to compare the transcriptional responses of
one non-Agg isolate (NCPF 8973) and one Agg isolate (NPCF 8978) of C. auris during
formation of biofilms from planktonic cells. These analyses indicated that several key
cell membrane and cell wall components were upregulated in Agg biofilms, many of
which are involved in cell adhesion to abiotic surfaces and host cells. These observa-
tions led us to pose the question: how would the host respond to the two phenotypes?
As such, we document for the first time an investigation into the host skin epithelial
response to Agg and non-Agg C. auris.
Given the clear differences in virulence traits of the non-Agg and Agg phenotype,
we deemed it pertinent to study in greater detail the transcriptional profiles of one
non-Agg isolate and one Agg isolate of C. auris. These two isolates displayed the
heterogeneity exhibited by other Agg and non-Agg isolates, with the NCPF 8973 isolate
forming a denser biofilm after 24 h (as shown here in Fig. 1 by the red data points and
elsewhere [10]). It must be noted here that the non-Agg C. auris isolates showed high
variation in biofilm-forming capabilities, with the NCPF 8973 isolate forming a biofilm
with greater biomass than the other isolates in the group. In contrast, the Agg isolate
selected (NCPF 8978) was an intermediate biofilm former among its group. Neverthe-
less, irrespective of the biofilm-forming capabilities, transcriptome analyses showed
that an increased number of genes was upregulated in the Agg biofilm compared to
the non-Agg biofilm of the two isolates selected (450 versus 194 genes, respectively;
Fig. 2), suggestive that the clustering of aggregated cells greatly impacts the transcrip-
tome of the organism during the formation of a biofilm. Of these differential responses
in the two biofilm phenotypes, a vast number of genes upregulated in the Agg biofilm
belonged to CC as assessed using GO analyses. Specifically, several cell wall genes were
upregulated in the Agg phenotype, e.g., TSA1, ECM33, MP65, ALS1, and PHR1. In C.
albicans, ECM33 and MP65 have been deemed important proteins in maintenance of
fungal cell wall integrity, biofilm formation, and stress responses (29–31). Furthermore,
the ALS family of adhesin proteins and PHR family of extracellular transglycosylases also
function as important regulators of biofilm formation in C. albicans (32, 33). For
example, loss of function of PHR and ALS proteins results in impaired adhesion and
biofilm development (34, 35). It must be noted here that such direct comparisons in
transcriptional responses between findings on C. auris and C. albicans biofilms must be
taken with a certain degree of caution, given the lack of true hyphal formation by C.
auris isolates grown in biofilms (6), although such a trait can be induced under some
conditions (7, 14). An absence of hyphae in C. auris during biofilm formation could
impact the transcriptional response by the organism compared to other Candida
species, especially given that proteins such as ALS have been shown to be upregulated
and involved in the yeast-to-hypha transition in C. albicans (36, 37). Nevertheless, such
in-depth analyses, as those documented herein, may begin to explain the mechanisms
behind aggregate formation in biofilms of some C. auris isolates.
Most of the aforementioned genes (TSA1, ECM33, MP65, ALS1, and PHR1) have
multiple functions in C. albicans pathogenicity, particularly in biofilm formation as
discussed above. In addition, most also play key roles in attachment and/or survival
within the host in other fungal species. For example, TSA1, which encodes a protein
called thiol-specific antioxidant 1, has been identified in C. albicans and Cryptococcus
neoformans, and functions as an important stress response regulator in unfavorable
oxidative environments (38, 39), potentially those generated by the host (40). In C.
albicans, ECM33,MP65, and PHR1 have been shown to be important genes necessary for
production of proteins involved in adherence and invasion of host cells (29–31, 34). For
example, in similar three-dimensional reconstituted skin and oral epithelial coculture
models, heterozygous mutants of ECM33 and PHR1 displayed clear deficiencies in
penetration of epithelial cell layers leading to reduced tissue invasion and subsequent
cellular damage (30, 34). Finally, another gene upregulated in Agg C. auris biofilms was
ALS1, a member of the ALS family of adhesin proteins. This cohort of adhesin proteins
which contains at least eight members in C. albicans are well-documented virulence
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factors, particularly in host-pathogen interactions in vitro and in vivo (25, 32, 41).
Concerning the results shown in this study, the role of ALS1, which encodes the protein
Als1p, in Candida-host interactions remains unclear. As such, contradictory reports state
a role for this adhesion in attachment to epithelial cells. Kamai and colleagues showed
that heterozygous knockouts of ALS1 were unable to colonize oral tissues of mice in
vivo and ex vivo as efficiently as wild-type strains or knockouts coupled with the Als1p
reinstated (42). In contrast, it was shown that attachment of the C. albicans ALS1 null
mutant to oral epithelial cells was no different than that of wild-type controls, sug-
gesting that its role in adhesion was not as important as other ALS family members (26).
Nevertheless, as discussed briefly above, such comparisons between C. auris and C.
albicans interactions with host cells must be tentatively compared given the differences
in the morphological forms of the two species. In particular, the transition from yeast
to hyphae in C. albicans is essential for tissue invasion of mucosal surfaces. For example,
fungal invasion mechanisms have been identified that show morphological changes
from yeast to pseudohyphae to hyphae during the process of adhesion and invasion in
C. albicans in epithelial tissue (43, 44). This process is even essential for the discrimi-
nation of commensal and pathogenic forms of C. albicans by the host (45). Given its
inability to form hyphae under normal physiological conditions, how C. auris can invade
epithelial tissue is unknown. It is possible that the organism has different invasive
mechanisms from other Candida species, including possible variations among isolates
from different clades. However, at this juncture, further studies are necessary to
elucidate such mechanisms, including consideration of the virulence properties of
various non-Agg and Agg isolates.
It has been postulated that C. auris exhibits a level of immune evasion to bypass
immunological defenses (4). Recent work by Johnson et al. showed that C. auris was
resistant to neutrophil-mediated killing by failing to stimulate neutrophil elastase trap
(NET) formation both in vitro and in vivo in a zebrafish infection model (16). Another
study found that viable C. auris did not induce an inflammatory response in human
peripheral blood mononuclear cells (PBMCs), although fungal cells were recognized
and engulfed by human monocyte-derived macrophages. Conversely, such host re-
sponses were significantly greater against other Candida species such as Candida
tropicalis, Candida guilliermondii, and Candida krusei (46). It is apparent from these
studies that the host recognizes yet fails to generate an effective immune response
against C. auris. From the results described here, it is evident that C. auris is not
cytotoxic nor proinflammatory to intact skin epithelial cells or epidermis tissue. Only
following induction of a wound in these models did C. auris elicit any significant
response by the host. From this, it could be suggested that under normal immuno-
logical conditions, the organism is noninvasive, and any immune response from the
host is minimal. Confirming this, previous studies have shown that immunocompetent
mice were more resistant to C. auris infection than immunocompromised mice (15).
Such findings have been seen in humans; invasive C. auris infections generally occur in
critically ill patients with serious underlying medical conditions resulting in hemato-
logical deficiencies and/or immunosuppression (47–49). These observations from ani-
mal models and human studies are suggestive that an effective immune system is
required to prevent C. auris infection. In the context of this study, the observed
noninvasive phenotype of C. auris may simply be due to lack of hyphal formation,
whereby yeast cells colonize the periphery of the skin yet do not invade the underlying
layers unless in the presence of a wound. Indeed, similar observations have been made
elsewhere. Horton et al. recently showed that C. auris forms layers of cells on the
periphery of porcine skin ex vivo, but these C. auris structures were devoid of pseudo-
hyphae or hyphae (17). Until further studies commence, we cannot comment on
whether the observed interactions with the host tissue are homogenous among the
non-Agg and Agg phenotypes.
A limitation from previous studies is the failure to investigate the host response to
the Agg phenotype expressed by certain isolates. We and others have previously shown
that the non-Agg isolates of C. auris are more virulent in G. mellonella larval models
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than the Agg counterparts, possibly resulting from enhanced dissemination rates of the
single cells (6, 10). Here, the Agg NCPF 8978 isolate was significantly more cytotoxic and
proinflammatory than non-Agg NCPF 8973 in the two- and three-dimensional skin
models. At this juncture, it is unknown why such a response occurs in the host. Murine
models of candidiasis have shown that C. auris can accumulate in the kidneys of mice
in the form of aggregates (7, 12, 13), suggesting that aggregation may occur in vivo to
enable persistence and survival. However, to date, no studies have investigated the
host response to such C. auris aggregates in vivo. It could simply be that the Agg
phenotype generates a cluster of cells with increased pathogenic traits to induce a
greater host response than single cells. This was confirmed by the upregulation of two
key adhesin and proteinase genes, ALS5 and SAP5, in the Agg NCPF 8978 isolate
compared to non-Agg NCPF 8973 in the skin epidermis model. Interestingly, similar
observations have been reported for biofilm-dispersed single cells versus aggregates in
model bacteria such as Pseudomonas aeruginosa. As such, dispersed aggregates of P.
aeruginosa possess enhanced antibiotic resistance traits, likely due to encapsulation by
extracellular matrix, and greater immune evasion techniques over dispersed single cells
(50–52). Conversely, it could be argued that the single-cell phenotype of C. auris
exhibits a level of immune evasion (as postulated elsewhere [16, 53]), which may
explain the lack of response by the host to this phenotype. Future studies must
continue to investigate the unique Agg phenotype of C. auris to fully clarify the
organisms’ pathogenic mechanisms. These investigations must consider interactions
between C. auris and other organisms that comprise the skin and/or wound micro-
biomes, which may function as important beacons for host invasion of C. auris.
The identification of five geographically and phylogenetically distinct clades of C.
auris (2, 9), containing isolates capable of forming aggregates with enhanced drug
resistance, has meant that unravelling the pathogenic mechanisms employed by C.
auris in vitro and in vivo remains extremely difficult. This study has highlighted different
pathogenic signatures of Agg and non-Agg forms of C. auris in biofilms and during host
invasion in vitro, albeit with only one other isolate from each phenotypic group. Of
course, given the level of heterogeneity among isolates, in-depth analyses from this
work are limited to one Agg isolate and one-Agg isolate. At this juncture, it is unknown
whether other isolates behave in a manner similar to the two isolates described in this
study, and this warrants further consideration moving forward. The level of heteroge-
neity observed among isolates in regard to the non-Agg/Agg phenotype may arise
from different unique transcriptional responses between the groups. As such, future
studies must continue to investigate these unique phenotypic traits of different Agg
and non-Agg isolates of C. auris from different clades to fully understand the persis-
tence of this nosocomial pathogen in the health care environment and whether such
traits are comparable among the diverse isolates.
MATERIALS AND METHODS
Microbial growth and standardization. For in vitro biofilm biomass assessment, a pool of aggre-
gating (Agg; n 12) and single-celled, nonaggregative (non-Agg; n 14) C. auris clinical isolates (gift
from Andrew Borman and Elizabeth Johnson, Public Health England, UK). The isolates used and the
clades they belong to are shown in Table 1. All C. auris isolates were stored in Microbank beads (Pro-Lab
Diagnostics, UK) prior to use. Each isolate was grown on Sabouraud dextrose (SAB) agar (Oxoid, UK) at
30°C for 24 to 48 h and then stored at 4°C prior to propagation in yeast-peptone-dextrose (YPD;
Sigma-Aldrich, UK) medium overnight (16 h) at 30°C, gently shaking at 200 rpm. The cells were pelleted
by centrifugation (3,000 g) and then washed two times in phosphate-buffered saline (PBS). The cells
were then standardized to the desired concentration after counting using a hemocytometer and then
resuspended in selected media for each assay, as described in this article.
C. auris isolate phenotypes were determined visually by suspending one colony in 1 ml of PBS
(Sigma-Aldrich, UK). Isolates were termed “aggregators” if the added colony did not disperse upon
mixing in PBS. For RNA sequencing and transcriptional analysis of C. auris biofilms and coculture systems,
one Agg isolate (NCPF 8978) and one non-Agg isolate (NCPF 8973) were used.
Biofilm growth and biomass assessment. Fungal cells were adjusted to 1 106 cells/ml in Roswell
Parks Memorial Institute (RPMI) medium (Sigma-Aldrich, UK), and biofilms formed for 4 or 24 h at 37°C
in flat-bottom wells of 96-well plates (Corning, UK). Appropriate medium controls were included on each
plate to test for contamination. Following incubation, biofilms were washed gently once in PBS to
remove any nonadhered cells. The biomass of each biofilm was determined via 0.05% crystal violet (CV)
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staining as described previously (54). Absorbance of the CV stain was measured spectrophotometrically
at 570 nm in a microtiter plate reader (FLUOStar Omega, BMG Labtech, UK).
Monitoring the growth of Candida auris biofilms in real time. The xCELLigence real-time cell
analyzer (RTCA; ACEA Bioscience Inc., San Diego, CA) was used to monitor the formation of C. auris
biofilms in real time using electron impedance measurements (presented as cell index [CI]) which is
directly related to cell attachment and proliferation. In brief, the E-plate containing 100 l of preheated
RPMI medium was loaded into the RTCA which had been placed in the incubator 2 h prior to the
experiment to test medium impedance and electrode connectivity. The cultures of each C. auris isolate
used in this study were standardized to 2 106 CFU/ml and added to the E-plate in 100-l aliquots in
triplicate. Appropriate medium controls minus inoculum were also included in triplicate. Biofilm forma-
tion was measured over 24 h with CI readings taken every 5 min. Normalized CI values were exported
from the RTCA software and analyzed in GraphPad Prism (version 8; GraphPad Software Inc., La Jolla, CA).
More-detailed descriptions of this technology can be found elsewhere (55).
Two-dimensional monolayer coculture model. Adult human epidermal keratinocyte (HEKa) cells
(Invitrogen, Gibco, UK) were used for two-dimensional coculture experiments. Frozen stocks of HEKa cells
(1 106 cells/ml; passage number lower than 10) were revived and seeded in T-75 tissue culture flasks
(Corning, UK) in medium 154 (Thermo-Fisher, UK) supplemented with 100 U/ml of penicillin (Pen)/
streptomycin (Strep) and human keratinocyte growth supplement (HKGS) (Thermo-Fisher, UK). The flasks
were incubated at 37°C (5% CO2), and the medium was changed every 48 h until the cells reached 80
to 90% confluence (56). Confluent cells were passaged using 0.05% trypsin EDTA (Sigma-Aldrich, UK), and
the enzymatic reaction was inhibited using trypsin neutralizer solution (Sigma-Aldrich, UK). Passaged
cells were then seeded into 24-well plates (Corning, UK) at a final concentration of 2 105 cells/ml. After
24 to 48 h, the cells reached adequate confluence for C. auris coculture experiments as described below.
Three-dimensional human epidermis coculture model. Reconstituted human epidermis (RHE)
used for 3D coculture experiments was purchased from Episkin (Skin Ethic; Episkin, Lyon, France). RHE
was formed from healthy human keratinocytes cultured on an inert polycarbonate filter at the air-liquid
interface, in a chemically defined medium grown to 17-day maturity. This model is histologically similar
to in vivo human epidermis. Upon arrival and prior to experimental set-up, RHE was incubated with
maintenance medium in 24-well plates (Corning, UK) for 24 h with 5% CO2 at 37°C. Maintenance medium
was replaced, and then the coculture three-dimensional system was set up as described below.
Wound model in two-dimensional and three-dimensional coculture systems. HEKa cell mono-
layers were scratched using a method similar to a previously described method to mimic a wound model
(57, 58). Briefly, monolayers were grown to confluence as described above, and then three parallel
scratches were introduced across the surface using a 100-l pipette tip prior to inoculation with C. auris.
For RHE, a 19-gauge needle was used to scratch the tissue. For all coculture experiments, Agg C. auris
TABLE 1 Candida auris isolates used in this studya



























aAll isolates used in the preliminary experiments in this study (as seen in Fig. 4). The aggregative phenotype
and clade for each isolate are also shown. The two isolates (NCPF 8973 and NCPF 8978) selected for
transcriptional analyses and coculture experiments are indicated by an asterisk.
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NCPF 8978 and non-Agg C. auris NCPF 8973 were grown as described above and then standardized to
2 106/ml (multiplicity of infection [MOI] of 10 to HEKa cells; MOI of 10 and as previously described for
Candida-tissue coculture [23]). For the two-dimensional system, 2 106/ml C. auris was prepared in 500
l supplemented medium 154 and added directly to the confluent HEKa cells. For the three-dimensional
coculture model, 2 106/ml C. auris was prepared in 100 l of sterile PBS, and this suspension was added
directly to the RHE tissue. All experiments were conducted for 24 h at 5% CO2. Infected nonscratched
HEKa cells and RHE tissue were used as controls, e.g., no wound, and uninoculated cocultured cells or
tissues were also included for all experiments. All control and wounded models were infected in triplicate
with both isolates of C. auris.
Histological staining of skin epidermis. Following coculture with C. auris, epithelial tissue was
carefully cut from the 0.5-cm2 insert using a 19-gauge needle and washed three times in sterile PBS to
remove nonadherent cells in a manner similar to the previously described method (59), as summarized
in the schematic in Fig. 4. Tissue was then fixed in 10% neutral buffered formalin prior to embedding in
paraffin. A Finnesse ME microtome (Thermo Scientific, UK) was used to cut 2-m sections, and tissue
sections were stained with hematoxylin and eosin or with the fungus-specific periodic acid-Schiff (PAS)
reagents and counterstained with hematoxylin.
Epithelial cell viability. To assess any cytotoxic effects of C. auris on HEKa cells and RHE tissue, a
Pierce lactate dehydrogenase (LDH) cytotoxicity assay kit (Thermo Scientific, UK) was used according to
the manufacturers’ instructions. Following coculture, cell or tissue spent medium was assayed using the
above kit to quantify the level of LDH release as a measure of host cellular disruption.
Differential gene expression analysis. HEKa cells and RHE tissue following coculture were lysed in
RLT lysis buffer (Qiagen Ltd., UK) containing 0.01% (vol/vol) -2-mercaptoethanol (2ME) before bead
beating. All RNA was extracted using the RNeasy minikit according to the manufacturer’s instructions
(Qiagen Ltd., UK) and quantified using a NanoDrop 1000 spectrophotometer (Thermo Scientific, UK). RNA
was converted to complementary DNA (cDNA) using the High Capacity RNA to cDNA kit (Life Technol-
ogies, UK) per the manufacturer’s instructions. Gene expression was assessed using SYBR GreenER
based-quantitative PCR (qPCR) or RT2 profiler arrays (Qiagen Ltd., UK). For SYBR GreenER based-qPCR
analyses, the following PCR thermal profiles was used; holding stage at 50°C for 2 min, followed by
denaturation stage at 95°C for 10 min, and then 40 cycles, with 1 cycle consisting of 95°C for 3 s and 60°C
for 15 s. qPCR plates were run on the StepOnePlus real-time PCR system. The following primer sequences
were used for SYBR GreenER-based-qPCR analyses of host cells: for GAPDH, forward primer, 5= to 3=,
CAAGGCTGAGAACGGGAAG, and reverse primer, 5= to 3=, GGTGGTGAAGACGCCAGT (60); for IL-8, forward
FIG 4 Schematic diagram depicting the experimental set up for the three-dimensional coculture of skin
epidermis and Candida auris. A 17-day mature reconstructed human epidermis (RHE) on 0.5-cm2 inserts
was purchased from Episkin (Skin Ethic). (A) Inserts were carefully lowered into 24-well plates containing
maintenance medium supplied by the company. (B) To assess the host response to aggregative and
nonaggregative C. auris, control and wounded tissue was cocultured with both isolates (NCPF 8973 and
NCPF 8978). A total of 2 106 fungal cells in 100 l PBS was added to the tissue and incubated overnight
at 37°C and 5% CO2. For some tissues, prior to the addition of fungal inoculum, three scratch wounds
were induced using a sterile 19-gauge needle across the surface of the tissue. For visual representation
of phenotype, scanning electron microscopy images of 24-h biofilms are included in panel B, clearly
showing the differences in cellular phenotypes between the two C. auris isolates. These images were
taken at1,000 magnification as viewed under a JEOL JSM-6400 scanning electron microscope (samples
processed as previously described [70]). Image created using Biorender.
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primer, 5= to 3=, CAGAGACAGCAGAGCACACAA, and reverse primer, 5= to 3=, TTAGCACTCCTTGGCAAAAC
(61). For gene expression analyses of C. auris, primers for adhesin gene ALS5 and proteinase gene SAP5
were used as follows: for ALS5, forward primer, 5= to 3=, ATACCAGGGTCGGTAGCAGT, and reverse primer,
5= to 3=, CTATCTTCGCCGCTTGGGAT, and for SAP5, forward primer, 5= to 3=, GGATGCAGCTCTTCCTGGTT,
and reverse primer, 5= to 3=, CTTCCAGTTTGCGGTTGTGG. For other gene expression analyses of RHE
tissue, a custom-designed RT2 Profiler PCR array was compiled containing primers for genes associated
with inflammation and fungal recognition or stimulation of host tissue. For these arrays, the following
thermal cycle was used on the MxProP quantitative PCR machine; 10 min at 95°C, followed by 40 cycles,
where 1 cycle consisted of 15 s at 95°C and 60 s at 60°C. Data were assembled using MxProP 3000
software (Stratagene, Netherlands). Expression levels for all genes of interest were normalized to the
housekeeping gene, -actin for C. auris gene expression and GAPDH for mammalian cells, according to
the 2ΔCt method, and then quantified using the 2ΔΔCt method (62).
RNA sequencing. For RNA sequencing of C. auris biofilms, RNA was extracted from 24-h C. auris
biofilms as described previously (63). In brief, biofilms were grown as described above on Thermanox
coverslips (Thermo-Fisher, UK) in 24-well plates (Corning, UK). The biofilms were removed from the
coverslips by sonication at 35 kHz for 10 min in a sonic bath in 1 ml of PBS, and the sonicate was
transferred to a 2.0-ml RNase-free bead beating tube (Sigma-Aldrich, UK). The cells were homogenized
in TRIzol (Invitrogen, UK) with 0.5-mm glass beads using a BeadBug microtube homogenizer for a total
of 90 s (Benchmark-Scientific, USA). RNA was then extracted as described above using the RNeasy minikit
according to the manufacturer’s instructions (Qiagen Ltd., UK). Following extraction, RNA quality and
quantity were determined using a Bioanalyzer (Agilent, USA), where a minimum RNA integrity number
and quantity of 7 and 2.5 g, respectively, were obtained for each sample. Annotation of data following
sample submission to Edinburgh Genomics (http://genomics.ed.ac.uk/) was completed as previously
described (28). Briefly, raw fastq reads were trimmed and aligned to the Candida auris representative
genome B8441 using Hisat2 (64). Reads were then processed and assembled de novo using the Trinity
assembly pipeline (65). Trinotate and Blast2Go were utilized to assign gene identifiers (IDs) to homolo-
gous sequences using BLAST and Interpro (66, 67). Differential expression analysis was performed
according to the DESeq2 pipeline, and functional overrepresentation was determined using GOseq (68,
69) within R. All transcriptional analyses reported for one isolate were calculated in reference to the other
isolate and vice versa. Additionally, visualization of overrepresented pathways were drawn within R.
Statistical analysis. Statistical analyses were performed using GraphPad Prism. Two-tailed paired or
unpaired Student’s t tests were used to compare the means of two samples as stated within this article
or one-way analysis of variance (ANOVA) to compare the means of more than two samples. Tukey’s
posttest was applied to the P value to account for multiple comparisons of the data. P values of 0.05
were considered statistically significant.
Data availability. Raw data files for these analyses are deposited in BioProject under accession no.
PRJNA477447, as previously published by our research group (28). SRA files can be found under
accession no. SRS3447362 (NCPF 8973) and SRS3447363 (NCPF 8978).
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